BSE filing, NSE: VEDL. Summary written from the filing by ALFA Finder's alert engine.
Vedanta Ltd: key numbers
- Share price
- ₹233.05
- Market cap
- ₹91,132 Cr
- Revenue (annual)
- ₹78,437 Cr
- Net profit (annual)
- ₹17,391 Cr
- P/E (TTM)
- 4.2×Sector 16.7×
- Promoter holding
- 54.72%+0.00% QoQ
- FII holding
- 15.78%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vedanta Ltd
All →Vedanta Earnings Call Transcript: Key Takeaways
Vedanta delivered record revenue and EBITDA driven by operational execution and cost management post-demerger.
Vedanta Results Update
Vedanta files its Q2/H1 FY27 press release and investor presentation alongside board-approved results. The release reports record quarterly performance and declares a ₹5 per share interim dividend.
- Zinc International MIC capacity
- 500 ktpa
Vedanta Q2 FY27 Results: Net Profit ₹6,202 Cr, Up 78.3% YoY
Vedanta Ltd reported revenue from operations of ₹26,356 Cr (+57.5% YoY) and net profit of ₹6,202 Cr (+78.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹6,202 Cr · +78.3% YoY
Vedanta Employee Stock Options
Vedanta's NRC approved 99,32,834 performance-based ESOPs under VEDL ESOS 2026. Options vest over 36 months at par value ₹1 per share.
Vedanta Other Announcement
Vedanta filed its Integrated Filing (Governance) for the quarter ended September 30, 2026, covering the Corporate Governance Report and investor complaints status. The filing is a routine compliance submission with no financial or business event.
Vedanta Board Meeting Date
Vedanta Ltd scheduled its board meeting for October 28, 2026, to consider Q2/H1 unaudited results. Trading window closes from October 1 to 30 for designated persons.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.